Press releases
- Press releases
- Browse
Press releases
Two new Clinical Study reports of Neo-Penotran® Forte are to be presented at the 10'th International Congress on Infectious Diseases meeting to be held in Singapore between 11-14 March 2002. More
HEALTHPOINT Canada, a division of HEALTHPOINT Ltd., , began marketing COOK Biotech Incorporated's patented wound matrix product, Oasis, in Canada this month through a distribution partnership with Trudell Medical Marketing Limited. More
"MENOPUR(tm) is at least as effective and well tolerated as genetically-engineered, so called recombinant FSH in women undergoing in-vitro fertilisation treatment" More
Zambon and APR have recently signed a Strategic Alliance and License Agreement for the further development and marketing of innovative patented consumer oriented products in patch form. More
Questcor Signs Agreement With Beacon Pharmaceuticals to Market H.P. Acthar Gel in the United Kingdom
Questcor Pharmaceuticals has signed an agreement with Beacon Pharmaceuticals of Tunbridge Wells, Kent, UK, for the exclusive marketing and distribution of H.P. Acthar(R) Gel in the United Kingdom. More
Zambon will license Vectura's PowderHale(tm) pulmonary formulation technology for the development and commercialisation of a new dry powder inhaler product. More
Zambon and APR Applied Pharma Research S.A. have signed an international license agreement for the further development of innovative patented products in matrix patch form More
Healthpoint Ltd. has announced that the United States Patent and Trademark Office has granted Healthpoint a Notice of Allowance on its patent application for the ointment vehicle that is the basis for Healthpoint's Xenaderm(tm). More
Astex Technology today announced the receipt of a milestone payment from Aventis Pharmaceuticals, as part of a structural biology research agreement focused on solving novel human cytochrome P450 Crystal Structures More
Rapid In-vitro Percutaneous Penetration Profile of Sulidin® 1% Nimesulide LPS topical gel to be presented at the 8'th International Conference on Percutaneous Penetration. More
Related Reports
Market Research Reports provided by reports.iptechex.com
Jun 2010 - 68 pages - $5,700
Jun 2010 - 64 pages - $5,700
Mar 2010 - 75 pages - $5,700
Dec 2009 - 121 pages - $7,600
Dec 2009 - 84 pages - $7,600
Jan 2011 - 90 pages - $5,700
Dec 2010 - 37 pages - $5,700
Nov 2010 - 111 pages - $5,700
Apr 2011 - 104 pages - $3,800
Apr 2008 - 61 pages - $495
Your selection
Browse By
- Therapeutic target
- Accident and Trauma
- Allergy
- Blood and forming organs
- Cardiovascular
- Central Nervous System
- Dermatological
- Endocrinology
- Gastrointestinal
- Genetic disorders
- Genito-urinary
- Hospital and Surgery
- Immune related disorders
- Infectious diseases
- Metabolism
- Musculoskeletal
- Oncology
- Oral Health
- Other therapeutic
- Respiratory
- Sensory organ
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us